外显子组测序在纤毛病相关肾病大队列中的应用
本研究对42例临床诊断为肾单位肾痨(NPH)且靶向基因面板未检出致病变异的无关先证者进行外显子组测序(ES),26%的患者检出致病或可能致病变异,涉及已知肾病基因及多系统疾病基因,并发现SSBP1可能为综合征性肾小管间质性肾病的新候选基因。
要点
- ES在26%的NPH病例中检出致病变异,扩展了经典纤毛病面板之外的基因。
- ES发现被误诊为纤毛病相关肾病的GN和肾小管肾病基因,提示诊断重叠。
- 非纤毛基因变异患者可表现为纤毛病样肾外症状,提示表型拷贝。
核心结论
- ES可提高NPH诊断准确性,识别已知肾病基因、非肾脏疾病基因及多系统疾病基因的致病变异。
- SSBP1与肾小管间质性肾病的关联可能为纤毛病发病机制提供新见解。
研究设计与样本
- 对42例临床诊断为NPH的无关先证者,在靶向纤毛病相关基因面板未检出诊断性变异后行外显子组测序。
- NPH临床诊断定义为生命前二十年进展至肾衰竭的囊性肾病,或非特异性CKD伴提示纤毛病的肾外特征。
主要发现
- 42例中11例(26%)检出致病或可能致病变异,涉及LAMB2、COQ8B、COL4A3、MUC1及AGXT。
- 6例检出可解释肾外表型但无相应肾脏疾病的致病变异,涉及APTX、TUBB3、DHX38、IQCE、CRX、RPGR。
- 3例检出意义未知变异,另3例检出隐性疾病相关基因的杂合变异。
- 发现SSBP1为综合征性肾小管间质性肾病的潜在候选基因,提示线粒体功能障碍新通路。
临床怎么用
- 对靶向面板未解决的NPH患者,可考虑外显子组测序以提高诊断率。
- ES结果有助于指导特异性诊断和治疗方案,尤其在不完全或非典型病例中。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
KEY POINTS: Exome sequencing solved 26% of nephronophthisis cases, identifying nephropathy and extrarenal disease genes beyond classic ciliopathy panels. Exome sequencing uncovered GN and tubular nephropathy genes misdiagnosed as ciliopathy-associated nephropathy, underscoring diagnostic overlap in kidney diseases. Patients with nonciliary genetic variants may present with ciliopathy-like extrarenal symptoms, showing phenocopies in kidney ciliopathy diagnostics. BACKGROUND: Nephronophthisis (NPH) is an autosomal recessive tubulointerstitial kidney disease and a leading genetic cause of chronic kidney failure in children and young adults. As a ciliopathy, NPH is caused by biallelic variants in genes encoding proteins involved in the structure and function of primary cilia. The broad clinical spectrum of NPH results in a clinically and genetically heterogeneous disease, posing diagnostic challenges and leaving approximately 30% of cases unresolved with current gene panels. METHODS: After targeted gene panel for ciliopathy-associated genes failed to identify diagnostic variants, exome sequencing (ES) was conducted on 42 unrelated index patients with a clinical diagnosis of NPH, defined as cystic nephropathy progressing to kidney failure within the first two decades of life, or by unspecific CKD accompanied by extrarenal features indicative of a ciliopathy. RESULTS: Pathogenic or likely pathogenic variants were identified in 11 of the 42 patients (26%). Variants were detected in known nephropathy genes ( LAMB2 , COQ8B , COL4A3 , MUC1 ) and a multisystem disease gene with secondary kidney involvement ( AGXT ). In addition, ES elucidated deleterious variants explaining extrarenal phenotypes without corresponding kidney disease in six patients ( APTX , TUBB3 , DHX38 , IQCE, CRX , RPGR ). Variants of unknown significance were identified in three patients, while heterozygous variants in genes associated with recessive disease were observed in three others. A potential candidate gene for syndromic tubulointerstitial nephropathy, SSBP1 , was also identified, suggesting a novel pathway involving mitochondrial dysfunction. CONCLUSIONS: ES enabled the identification of pathogenic variants in known genes associated with kidney diseases, nonkidney conditions, and multisystem disorders with secondary kidney involvement, thereby improving diagnosis accuracy, even in incomplete or atypical cases, and guiding specific diagnostic and therapeutic approaches. The identification of SSBP1 in association with tubulointerstitial nephropathy may provide new insights into the pathogenesis of ciliopathies.
引用
- Petzold F, Jeanpierre C, Chen X, et al. Exome Sequencing in a Large Cohort with Ciliopathy-Related Kidney Disease. Clin J Am Soc Nephrol. 2025. PMID: 41343253. doi:10.2215/CJN.0000000905
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。